Purchases and Sales Made in Q4 2022 in An2 Therapeutics, Inc. (ANTX)
This table provides information about the institutional ownership of An2 Therapeutics, Inc. (ANTX) during Q4 2022. The information is specifically focused on institutions that hold shares of AN2 Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 10, 2023
Q4 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
405K+ 219.54% |
$3.45M - $7.97M
|
589K
$884K
|
|
Feb 13, 2023
Q4 2022
|
Black Rock Inc.
New York, NY |
BUY
|
- |
257K+ 136.45% |
$2.19M - $5.06M
|
445K
$668K
|
|
Feb 09, 2023
Q4 2022
|
Monashee Investment Management LLC
Boston, MA |
BUY
|
- |
217K+ 92.86% |
$1.84M - $4.27M
|
450K
$675K
|
|
Feb 13, 2023
Q4 2022
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
43.4K+ 115.87% |
$369K - $854K
|
80.8K
$121K
|
|
Feb 13, 2023
Q4 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
39.8K+ 47.78% |
$339K - $784K
|
123K
$185K
|
|
Feb 14, 2023
Q4 2022
|
State Street Corp
Boston, MA |
BUY
|
- |
37.3K+ 69.56% |
$318K - $735K
|
91K
$137K
|
|
Feb 14, 2023
Q4 2022
|
Woodline Partners LP
San Francisco, CA |
BUY
|
- |
31.2K+ 40.92% |
$265K - $613K
|
107K
$161K
|
|
Feb 14, 2023
Q4 2022
|
Bank Of New York Mellon Corp
New York, NY |
BUY
|
- |
30.9KNew |
$263K - $608K
|
30.9K
$46.3K
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
BUY
|
- |
22.3K+ 76.78% |
$190K - $440K
|
51.5K
$77.2K
|
|
Feb 14, 2023
Q4 2022
|
Nuveen Asset Management, LLC
Chicago, IL |
BUY
|
- |
15.1KNew |
$128K - $297K
|
15.1K
$22.6K
|
|
Feb 13, 2023
Q4 2022
|
Charles Schwab Investment Management Inc
San Francisco, CA |
BUY
|
- |
14.7K+ 144.36% |
$125K - $290K
|
24.9K
$37.3K
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
11.5K+ 87.71% |
$98.3K - $227K
|
24.7K
$37.1K
|
|
Jan 18, 2023
Q4 2022
|
Private Advisor Group, LLC
|
BUY
|
- |
11KNew |
$93.7K - $217K
|
11K
$16.5K
|
|
Feb 14, 2023
Q4 2022
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
10.1KNew |
$85.8K - $199K
|
10.1K
$15.1K
|
|
Feb 13, 2023
Q4 2022
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
3.64K+ 138.72% |
$31K - $71.7K
|
6.26K
$9.4K
|
|
Feb 10, 2023
Q4 2022
|
American International Group, Inc.
New York, NY |
BUY
|
- |
2.98K+ 130.58% |
$25.3K - $58.6K
|
5.26K
$7.88K
|
|
Feb 13, 2023
Q4 2022
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
BUY
|
- |
2.9K+ 153.92% |
$24.7K - $57.2K
|
4.79K
$7.18K
|
|
Feb 13, 2023
Q4 2022
|
Barclays PLC
London, X0 |
BUY
|
- |
2.78K+ 10.19% |
$23.7K - $54.7K
|
30.1K
$45.1K
|
|
Feb 14, 2023
Q4 2022
|
California State Teachers Retirement System
West Sacramento, CA |
BUY
|
- |
2.54K+ 134.09% |
$21.6K - $50K
|
4.44K
$6.65K
|
|
Jan 26, 2023
Q4 2022
|
Strs Ohio
|
BUY
|
- |
2.3KNew |
$19.6K - $45.3K
|
2.3K
$3.45K
|
|
Feb 14, 2023
Q4 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
1.69K+ 2867.8% |
$14.4K - $33.3K
|
1.75K
$2.63K
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
1.07K+ 2.66% |
$9.12K - $21.1K
|
41.3K
$62K
|
|
Feb 14, 2023
Q4 2022
|
Avidity Partners Management LP
Dallas, TX |
BUY
|
- |
970+ 0.13% |
$8.25K - $19.1K
|
744K
$1.12M
|
|
Feb 14, 2023
Q4 2022
|
Legal & General Group PLC
London, X0 |
BUY
|
- |
775+ 198.21% |
$6.6K - $15.3K
|
1.17K
$1.75K
|
|
Feb 10, 2023
Q4 2022
|
Amalgamated Bank
New York, NY |
BUY
|
- |
452+ 32.29% |
$3.85K - $8.9K
|
1.85K
$2.78K
|
|
Feb 02, 2023
Q4 2022
|
Nisa Investment Advisors, LLC
|
BUY
|
- |
10New |
$85.1 - $197
|
10
$15
|
|
Feb 09, 2023
Q4 2022
|
Citigroup Inc
|
BUY
|
- |
3+ 0.0% |
$25.5 - $59.1
|
135K
$202K
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-423- 33.07% |
$3.6K - $8.33K
|
856
$1.28K
|
|
Feb 14, 2023
Q4 2022
|
Bvf Inc
San Francisco, CA |
SELL
|
- |
-52.7K- 3.26% |
$448K - $1.04M
|
1.56M
$2.35M
|
|
Feb 14, 2023
Q4 2022
|
Alyeska Investment Group, L.P.
Chicago, IL |
SELL
|
- |
-57.3K- 54.19% |
$488K - $1.13M
|
48.4K
$72.6K
|